RS
JAZZ icon

Rakuten Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rakuten Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7K Buy
115
+111
+2,775% +$24.3K 0.01% 333
2026
Q1 		$756 Sell
4
-11
-73% -$1.92K ﹤0.01% 701
2025
Q4 		$2.55K Buy
15
+13
+650% +$1.99K ﹤0.01% 600
2025
Q3 		$264 Sell
2
-112
-98% -$13.4K ﹤0.01% 812
2025
Q2 		$12.1K Buy
114
+98
+613% +$10.6K ﹤0.01% 386
2025
Q1 		$1.99K Buy
16
+2
+14% +$261 ﹤0.01% 590
2024
Q4 		$1.72K Sell
14
-17
-55% -$2K ﹤0.01% 578
2024
Q3 		$3.45K Sell
31
-2
-6% -$219 ﹤0.01% 459
2024
Q2 		$3.52K Buy
33
+8
+32% +$880 ﹤0.01% 429
2024
Q1 		$3.01K Sell
25
-35
-58% -$4.29K ﹤0.01% 461
2023
Q4 		$7.38K Buy
+60
New +$7.49K 0.01% 312

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Rakuten Securities's JAZZ Position: Q2 2026 in Review

Rakuten Securities increased its Jazz Pharmaceuticals (JAZZ) stake by 2,775% in Q2 2026, buying an estimated $24.3K and bringing the position to 115 shares worth $27.7K. The position accounts for 0.01% of the portfolio, ranked #333.

Rakuten Securities first reported a position in JAZZ in Q4 2023 and has held it in 11 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Rakuten Securities held 115 shares of Jazz Pharmaceuticals worth $27.7K as of Q2 2026.
  • Rakuten Securities bought 111 Jazz Pharmaceuticals shares in Q2 2026, an estimated $24.3K.
  • Jazz Pharmaceuticals made up 0.01% of Rakuten Securities's portfolio in Q2 2026, its #333 holding.
  • Rakuten Securities first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.